GBS
MCID: GLL022
MIFTS: 61
|
Guillain-Barre Syndrome (GBS)
Categories:
Genetic diseases, Immune diseases, Neuronal diseases, Rare diseases
|
|
|
MalaCards integrated aliases for Guillain-Barre Syndrome:
Characteristics:Inheritance:
Guillain-Barre Syndrome:
Multigenic/multifactorial 58
Acute Inflammatory Demyelinating Polyradiculoneuropathy:
Multigenic/multifactorial 58
Variant of Guillain-Barre Syndrome:
Multigenic/multifactorial 58
Prevelance:
Guillain-Barre Syndrome:
1-9/100000 (Worldwide, United States, Europe, France)
1-5/10000 (Denmark, Egypt) 58
Acute Inflammatory Demyelinating Polyradiculoneuropathy:
1-9/100000 (Europe) 58
Age Of Onset:
Guillain-Barre Syndrome:
All ages 58
Acute Inflammatory Demyelinating Polyradiculoneuropathy:
All ages 58
Variant of Guillain-Barre Syndrome:
All ages 58
Classifications:
MalaCards categories:
Global: Rare diseases Genetic diseases Anatomical: Neuronal diseases Immune diseases
ICD10:
31
32
Orphanet: 58
![]() External Ids:
|
MedlinePlus Genetics: 42 Guillain-Barré syndrome is an autoimmune disorder that affects the nerves. Autoimmune disorders occur when the immune system malfunctions and attacks the body's own tissues and organs. In Guillain-Barré syndrome, the immune response damages peripheral nerves, which are the nerves that connect the central nervous system (the brain and spinal cord) to the limbs and organs. Specifically, the immune response affects a particular part of peripheral nerves called axons, which are the extensions of nerve cells (neurons) that transmit nerve impulses. Guillain-Barré syndrome can affect the neurons that control muscle movement (motor neurons); the neurons that transmit sensory signals such as pain, temperature, and touch (sensory neurons); or both. As a result, affected individuals can experience muscle weakness or lose the ability to feel certain sensations.Muscle weakness or paralysis are the characteristic features of Guillain-Barré syndrome. The weakness often begins in the legs and spreads to the arms, torso, and face and is commonly accompanied by numbness, tingling, or pain. Additional signs and symptoms of the condition include difficulty swallowing and difficulty breathing. Occasionally, the nerves that control involuntary functions of the body such as blood pressure and heart rate are affected, which can lead to fluctuating blood pressure or an abnormal heartbeat (cardiac arrhythmia).There are several types of Guillain-Barré syndrome, classified by the part of the peripheral nerve involved in the condition. The most common type of Guillain-Barré syndrome is acute inflammatory demyelinating polyradiculoneuropathy (AIDP). In AIDP, the immune response damages myelin, which is the covering that protects axons and promotes the efficient transmission of nerve impulses. In two other types of Guillain-Barré syndrome, acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN), the axons themselves are damaged by the immune response. In AMAN, only the axons of motor neurons are damaged. In AMSAN, the axons of sensory neurons are also damaged. Because of sensory nerve damage, affected individuals can lose the ability to sense the position of their limbs and can have abnormal or absent reflexes (areflexia).Miller Fisher syndrome, another type of Guillain-Barré syndrome, involves cranial nerves, which extend from the brain to various areas of the head and neck. Miller Fisher syndrome is characterized by three features: weakness or paralysis of the muscles that move the eyes (ophthalmoplegia), problems with balance and coordination (ataxia), and areflexia. People with this condition can have other signs and symptoms common in Guillain-Barré syndrome, such as muscle weakness.Guillain-Barré syndrome occurs in people of all ages. The development of the condition usually follows a pattern. Prior to developing the condition, most people with Guillain-Barré syndrome have a bacterial or viral infection. The first phase of Guillain-Barré syndrome, during which signs and symptoms of the condition worsen, can last up to four weeks, although the peak of the illness is usually reached in one to two weeks. During the second phase, called the plateau, signs and symptoms of Guillain-Barré syndrome stabilize. This phase can last weeks or months. During the recovery phase, symptoms improve. However, some people with Guillain-Barré syndrome never fully recover and can still experience excessive tiredness (fatigue), muscle weakness, or muscle pain. MalaCards based summary: Guillain-Barre Syndrome, also known as guillain-barré syndrome, is related to chronic inflammatory demyelinating polyradiculoneuropathy and miller fisher syndrome, and has symptoms including tremor, back pain and ophthalmoplegia. An important gene associated with Guillain-Barre Syndrome is PMP22 (Peripheral Myelin Protein 22), and among its related pathways/superpathways are Cytokine Signaling in Immune system and IL-9 Signaling Pathways. The drugs Eculizumab and Complement System Proteins have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, brain and heart, and related phenotypes are acute demyelinating polyneuropathy and hyporeflexia NINDS: 52 Guillain-Barré syndrome (GBS) is a rare neurological disorder in which the body's immune system attacks part of the peripheral nervous system. It is one of several disorders involving weakness due to peripheral nerve damage caused by the person's immune system. Initial symptoms include unexplained sensations such as tingling in the feet or hands, or pain, followed by weakness on both sides of the body. The weakness can increase in intensity over a period of hours to days to weeks until the muscles cannot be used at all and the person is almost totally paralyzed. If breathing muscles are affected, the person is often put on a ventilator. Most individuals, however, have good recovery from even the most severe cases of GBS, although some continue to have some degree of weakness. The exact cause of Guillain-Barré syndrome is unknown. It can occur a few days or weeks after the person has had symptoms of a respiratory or gastrointestinal viral infection. Occasionally, surgery will trigger the syndrome. In rare instances, vaccinations may increase the risk of GBS. Recently, some countries worldwide have reported an increased incidence of GBS following infection with the Zika virus. A nerve conduction velocity (NCV) test, which measures the nerve's ability to send a signal, can aid the diagnosis. The cerebrospinal fluid that bathes the spinal cord and brain contains more protein than usual in someone with GBS, so a physician may decide to perform a spinal tap to obtain a sample of fluid to analyze. MedlinePlus: 41 Guillain-Barre syndrome is a rare disorder that causes your immune system to attack your peripheral nervous system (PNS). The PNS nerves connect your brain and spinal cord with the rest of your body. Damage to these nerves makes it hard for them to transmit signals. As a result, your muscles have trouble responding to your brain. No one knows what causes the syndrome. Sometimes it is triggered by an infection, surgery, or a vaccination. The first symptom is usually weakness or a tingling feeling in your legs. The feeling can spread to your upper body. In severe cases, you become almost paralyzed. This is life-threatening. You might need a respirator to breathe. Symptoms usually worsen over a period of weeks and then stabilize. Guillain-Barre can be hard to diagnose. Possible tests include nerve tests and a spinal tap. Most people recover. Recovery can take a few weeks to a few years. Treatment can help symptoms, and may include medicines or a procedure called plasma exchange. NIH: National Institute of Neurological Disorders and Stroke GARD: 19 Guillain-Barré syndrome (GBS) is a rare syndrome in which the body's immune system attacks part of the peripheral nervous system. The peripheral nervous system carries signals from the brain to the muscles. Symptoms of GBS include muscle weakness, numbness, and tingling sensations, which can increase in intensity until the muscles cannot be used at all (paralysis). The exact cause of Guillain-Barré syndrome is unknown. In most cases, GBS occurs a few days or weeks after symptoms of a viral infection. In rare cases, GBS may run in families. A diagnosis of GBS is suspected when a person has symptoms suggestive of the syndrome. A variety of tests, including a spinal tap, may be completed to confirm the diagnosis. Orphanet 58 Guillain-barre syndrome: A clinically heterogeneous spectrum of rare post-infectious neuropathies that usually occur in otherwise healthy patients and encompasses acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN), Miller-Fisher syndrome (MFS) and some other regional variants. Acute inflammatory demyelinating polyradiculoneuropathy: A rare inflammatory neuropathy belonging to the clinical spectrum of Guillain-Barré syndrome (GBS). CDC: 2 Guillain-Barré (Ghee-YAN Bah-RAY) syndrome (GBS) is a rare, autoimmune disorder in which a person's own immune system damages the nerves, causing muscle weakness and sometimes paralysis. GBS can cause symptoms that last for a few weeks to several years. Most people recover fully, but some have permanent nerve damage. Some people have died of GBS. Disease Ontology: 11 An autoimmune disease of peripheral nervous system that causes body's immune system to attack part of the peripheral nervous system. Wikipedia: 75 Guillain-Barré syndrome (GBS) is a rapid-onset muscle weakness caused by the immune system damaging the... more... |
Human phenotypes related to Guillain-Barre Syndrome:58 30 (show all 13)
UMLS symptoms related to Guillain-Barre Syndrome:tremor; back pain; ophthalmoplegia; headache; syncope; pain; chronic pain; sciatica; seizures; vertigo/dizziness; sleeplessness; cerebellar ataxia; neuralgia GenomeRNAi Phenotypes related to Guillain-Barre Syndrome according to GeneCards Suite gene sharing:25
MGI Mouse Phenotypes related to Guillain-Barre Syndrome:45
|
Drugs for Guillain-Barre Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):(show all 37)
Interventional clinical trials:(show top 50) (show all 55)
Inferred drug relations via UMLS 71 / NDF-RT 50 :
Cochrane evidence based reviews: guillain-barre syndrome |
Organs/tissues related to Guillain-Barre Syndrome:
MalaCards :
Spinal Cord,
Brain,
Heart,
Bone Marrow,
Skin,
T Cells,
Dorsal Root Ganglion
|
Articles related to Guillain-Barre Syndrome:(show top 50) (show all 11283)
|
|
Search
GEO
for disease gene expression data for Guillain-Barre Syndrome.
|
Pathways related to Guillain-Barre Syndrome according to GeneCards Suite gene sharing:(show all 18)
|
Cellular components related to Guillain-Barre Syndrome according to GeneCards Suite gene sharing:
Biological processes related to Guillain-Barre Syndrome according to GeneCards Suite gene sharing:(show all 13)
Molecular functions related to Guillain-Barre Syndrome according to GeneCards Suite gene sharing:
|
|